Literature DB >> 2173104

Congenital and perinatal cytomegalovirus infections.

C A Alford1, S Stagno, R F Pass, W J Britt.   

Abstract

Cytomegalovirus is the most common cause of congenital and perinatal viral infections throughout the world. Congenital infection occurs in 1% of all live births in developed countries and in an even higher percentage in developing nations. As a result of transmission during birth, by breast milk, and by blood transfusion, perinatal infections are much more prevalent than congenital infections. The vast majority of these infections are chronic, subclinical forms, but symptomatic infections are sufficiently prevalent and dangerous to represent a major unsolved public health problem throughout the world. In this review the epidemiologic, clinical, immunologic, and therapeutic facets of cytomegaloviral infections in pregnant women and their offspring will be discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2173104     DOI: 10.1093/clinids/12.supplement_7.s745

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  62 in total

1.  Human cytomegalovirus UL69 protein is required for efficient accumulation of infected cells in the G1 phase of the cell cycle.

Authors:  M L Hayashi; C Blankenship; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

Review 2.  Cytomegalovirus transmission from breast milk in premature babies: does it matter?

Authors:  P Bryant; C Morley; S Garland; N Curtis
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-09       Impact factor: 5.747

3.  Modification of the HCMV-specific IFN-γ release test (QuantiFERON-CMV) and a novel proposal for its application.

Authors:  Takahiro Kobayashi; Jun-Ichi Sato; Kazufumi Ikuta; Ryoko Kanno; Kyoko Nishiyama; Tetsuo Koshizuka; Ken Ishioka; Tatsuo Suzutani
Journal:  Fukushima J Med Sci       Date:  2017-06-22

Review 4.  Neonatal innate immunity to infectious agents.

Authors:  László Maródi
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

5.  Limits and patterns of cytomegalovirus genomic diversity in humans.

Authors:  Nicholas Renzette; Cornelia Pokalyuk; Laura Gibson; Bornali Bhattacharjee; Mark R Schleiss; Klaus Hamprecht; Aparecida Y Yamamoto; Marisa M Mussi-Pinhata; William J Britt; Jeffrey D Jensen; Timothy F Kowalik
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-06       Impact factor: 11.205

6.  Development of a high-throughput assay to measure the neutralization capability of anti-cytomegalovirus antibodies.

Authors:  Thomas J Gardner; Cynthia Bolovan-Fritts; Melissa W Teng; Veronika Redmann; Thomas A Kraus; Rhoda Sperling; Thomas Moran; William Britt; Leor S Weinberger; Domenico Tortorella
Journal:  Clin Vaccine Immunol       Date:  2013-02-06

7.  Clinical significance of cytomegalovirus infection in patients with inflammatory bowel disease.

Authors:  Elena Garrido; Elisa Carrera; Rebeca Manzano; Antonio Lopez-Sanroman
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

8.  Human cytomegalovirus reactivation during lactation and mother-to-child transmission in preterm infants.

Authors:  Johannes Meier; Uta Lienicke; Edda Tschirch; Detlev H Krüger; Roland R Wauer; Susanna Prösch
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

9.  Detection of human cytomegalovirus in urine samples by cell culture, early antigen assay and polymerase chain reaction.

Authors:  A Daiminger; G Schalasta; D Betzl; G Enders
Journal:  Infection       Date:  1994 Jan-Feb       Impact factor: 3.553

10.  Cytomegalovirus Infection in Pregnancy - Counselling Challenges in the Setting of Generalised Testing.

Authors:  Anca Maria Ciobanu; Nicolae Gica; Corina Gica; Radu Botezatu; Mirona Furtuna; Gheorghe Peltecu; Anca Maria Panaitescu
Journal:  Maedica (Bucur)       Date:  2020-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.